Antimalarial peroxides

• Main Authors: DEJAN M. OPSENICA, BOGDAN A. ŠOLAJA
• Format: Article
• Language: English
• Published: Serbian Chemical Society 2009-11-01
• Series: Journal of the Serbian Chemical Society
• Subjects: antimalarial; peroxides; trioxanes; trioxolanes; tetraoxanes; chimeras
• Online Access: http://www.shd.org.rs/JSCS/Vol74/No11/01-4430_3909.pdf

The problem of endemic malaria continues unabated globally. Malaria affects 40 % of the global population, causing an estimated annual mortality of 1.5–2.7 million people. The World Health Organization (WHO) estimates that 90 % of these deaths occur in sub-Saharan Africa among infants under the age of five. While a vaccine against malaria continues to be elusive, chemotherapy remains the most viable alternative towards treatment of the disease. During last years, the situation has become urgent in many ways, but mainly because of the development of chloroquine-resistant (CQR) strains of Plasmodium falciparum (Pf). The discovery that artemisinin (ART, 1), an active principle of Artemisia annua L., expresses a significant antimalarial activity, especially against CQR strains, opened new approaches for combating malaria. Since the early 1980s, hundreds of semisynthetic and synthetic peroxides have been developed and tested for their antimalarial activity, the results of which were extensively reviewed. In addition, in therapeutic practice, there is no reported case of drug resistance to these antimalarial peroxides. This review summarizes recent achievements in the area of peroxide drug development for malaria chemotherapy.